181 related articles for article (PubMed ID: 3081923)
1. Behavioral, biochemical, and blood pressure responses to alprazolam in healthy subjects: interactions with yohimbine.
Charney DS; Breier A; Jatlow PI; Heninger GR
Psychopharmacology (Berl); 1986; 88(2):133-40. PubMed ID: 3081923
[TBL] [Abstract][Full Text] [Related]
2. Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment.
Charney DS; Heninger GR
Arch Gen Psychiatry; 1985 May; 42(5):458-67. PubMed ID: 2859008
[TBL] [Abstract][Full Text] [Related]
3. Dose-response relationship for oral idazoxan effects in healthy human subjects: comparison with oral yohimbine.
Krystal JH; McDougle CJ; Woods SW; Price LH; Heninger GR; Charney DS
Psychopharmacology (Berl); 1992; 108(3):313-9. PubMed ID: 1355923
[TBL] [Abstract][Full Text] [Related]
4. Noradrenergic response to acute ethanol administration in healthy subjects: comparison with intravenous yohimbine.
McDougle CJ; Krystal JH; Price LH; Heninger GR; Charney DS
Psychopharmacology (Berl); 1995 Mar; 118(2):127-35. PubMed ID: 7617798
[TBL] [Abstract][Full Text] [Related]
5. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks.
Charney DS; Woods SW; Goodman WK; Heninger GR
Am J Psychiatry; 1987 Aug; 144(8):1030-6. PubMed ID: 3037926
[TBL] [Abstract][Full Text] [Related]
6. Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine.
Charney DS; Heninger GR; Redmond DE
Life Sci; 1983 Jul; 33(1):19-29. PubMed ID: 6865647
[TBL] [Abstract][Full Text] [Related]
7. The effects of caffeine on plasma MHPG, subjective anxiety, autonomic symptoms and blood pressure in healthy humans.
Charney DS; Galloway MP; Heninger GR
Life Sci; 1984 Jul; 35(2):135-44. PubMed ID: 6738307
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine and monoaminergic responses to acute administration of alprazolam in normal subjects.
Zemishlany Z; McQueeney R; Gabriel SM; Davidson M
Neuropsychobiology; 1990-1991; 23(3):124-8. PubMed ID: 2098668
[TBL] [Abstract][Full Text] [Related]
9. Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects.
Krystal JH; Webb E; Cooney NL; Kranzler HR; Southwick SW; Heninger GR; Charney DS
Am J Psychiatry; 1996 Jan; 153(1):83-92. PubMed ID: 8540598
[TBL] [Abstract][Full Text] [Related]
10. Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients.
Stine SM; Southwick SM; Petrakis IL; Kosten TR; Charney DS; Krystal JH
Biol Psychiatry; 2002 Apr; 51(8):642-51. PubMed ID: 11955464
[TBL] [Abstract][Full Text] [Related]
11. Plasma 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and growth hormone responses to yohimbine in panic disorder patients and normal controls.
Gurguis GN; Uhde TW
Psychoneuroendocrinology; 1990; 15(3):217-24. PubMed ID: 2255749
[TBL] [Abstract][Full Text] [Related]
12. Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder.
Charney DS; Heninger GR; Breier A
Arch Gen Psychiatry; 1984 Aug; 41(8):751-63. PubMed ID: 6742977
[TBL] [Abstract][Full Text] [Related]
13. Effects of yohimbine in obsessive compulsive disorder.
Rasmussen SA; Goodman WK; Woods SW; Heninger GR; Charney DS
Psychopharmacology (Berl); 1987; 93(3):308-13. PubMed ID: 2829264
[TBL] [Abstract][Full Text] [Related]
14. Assessment of alpha 2 adrenergic autoreceptor function in humans: effects of oral yohimbine.
Charney DS; Heninger GR; Sternberg DE
Life Sci; 1982 Jun; 30(23):2033-41. PubMed ID: 6287139
[TBL] [Abstract][Full Text] [Related]
15. alpha 2-Adrenergic receptor sensitivity in depression. The plasma MHPG, behavioral, and cardiovascular responses to yohimbine.
Heninger GR; Charney DS; Price LH
Arch Gen Psychiatry; 1988 Aug; 45(8):718-26. PubMed ID: 2840050
[TBL] [Abstract][Full Text] [Related]
16. Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients.
Charney DS; Woods SW; Krystal JH; Nagy LM; Heninger GR
Acta Psychiatr Scand; 1992 Oct; 86(4):273-82. PubMed ID: 1333719
[TBL] [Abstract][Full Text] [Related]
17. Methadone patients exhibit increased startle and cortisol response after intravenous yohimbine.
Stine SM; Grillon CG; Morgan CA; Kosten TR; Charney DS; Krystal JH
Psychopharmacology (Berl); 2001 Mar; 154(3):274-81. PubMed ID: 11351934
[TBL] [Abstract][Full Text] [Related]
18. Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder.
Charney DS; Heninger GR
Arch Gen Psychiatry; 1986 Nov; 43(11):1042-54. PubMed ID: 3021083
[TBL] [Abstract][Full Text] [Related]
19. Noradrenergic dysregulation during discontinuation of cocaine use in addicts.
McDougle CJ; Black JE; Malison RT; Zimmermann RC; Kosten TR; Heninger GR; Price LH
Arch Gen Psychiatry; 1994 Sep; 51(9):713-9. PubMed ID: 8080348
[TBL] [Abstract][Full Text] [Related]
20. Noradrenergic function in generalized anxiety disorder: effects of yohimbine in healthy subjects and patients with generalized anxiety disorder.
Charney DS; Woods SW; Heninger GR
Psychiatry Res; 1989 Feb; 27(2):173-82. PubMed ID: 2540501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
